Viewing Study NCT00023920


Ignite Creation Date: 2025-12-25 @ 4:09 AM
Ignite Modification Date: 2025-12-26 @ 3:07 AM
Study NCT ID: NCT00023920
Status: TERMINATED
Last Update Posted: 2013-01-23
First Post: 2001-09-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module